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RESUmEn
Objetivo: Evaluar la relación de los sínto-
mas depresivos y la calidad de vida en los 
usuarios de sustancias psicoactivas de los 
Centros de Atención Psicosocial de Mato 
Grosso. Método: Estudio transversal ana-
lítico realizado en los Centros de Atención 
Psicosocial con 109 usuarios. Se utilizaron 
los Instrumentos: Medical Outcomes Stu-
dy 36, el Inventario de Depresión de Beck, 
de variables sociodemográficas y del uso 
de sustancias psicoactivas. Se realizó el 
análisis de Tukey y la correlación de Spear-
man con nivel de significancia de α<0,05. 
Resultados: Los dominios más afectados 
de la calidad de vida fueron los aspectos 
emocionales, sociales y de salud mental, 
además de una fuerte correlación entre los 
síntomas depresivos y la calidad de vida. 
Conclusión: El uso de sustancias psicoacti-
vas y la presencia de síntomas depresivos 
interfieren significativamente en la vida de 
los usuarios, lo que puede comprometer la 
motivación para el tratamiento, afectando 
negativamente la calidad de vida de esta 
población.
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RESUmo
Objetivos: Avaliar a correlação entre a 
presença de sintomas depressivos e a qua-
lidade de vida em usuários de substâncias 
psicoativas dos Centros de Atenção Psicos-
social de Mato Grosso. Método: Estudo 
transversal analítico, realizado nos Centros 
de Atenção Psicossocial, com 109 usuários. 
Foram utilizados os instrumentos Medical 
Outcomes Study 36, Inventário de Depres-
são de Beck, variáveis sociodemográficas 
e do uso de substâncias psicoativas. Foi 
realizada a análise de Tukey e correlação 
de Spearman com nível de significância 
de α<0,05. Resultados: Os domínios mais 
afetados da qualidade de vida foram as-
pectos emocionais, sociais e de saúde 
mental, além de forte correlação entre 
sintomas depressivos e qualidade de vida. 
Conclusão: O uso de substâncias psicoati-
vas e a presença de sintomas interferem 
significativamente na vida dos usuários, o 
que pode comprometer a motivação para 
o tratamento, afetando negativamente a 
qualidade de vida desta população.
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AbStRACt
Objectives: To evaluate the correlation 
between the presence of depressive symp-
toms and quality of life in users of psycho-
active substances from Psychosocial Atten-
tion Centers in Mato Grosso. Method: A 
cross-sectional analytical study, conducted 
in Psychosocial Attention Centers, with 109 
users. The instruments used were: Medi-
cal Outcomes Study 36, Beck Depression 
Inventory, socio-demographic variables 
and the use of psychoactive substances. 
A Tukey analysis and a Spearman correla-
tion were conducted with a significance 
level of α<0,05. Results: The most affected 
domains of quality of life were emotional, 
social and mental health aspects, besides 
the strong correlation between depressive 
symptoms and quality of life. Conclusion: 
The use of psychoactive substances and 
the presence of symptoms significantly in-
terfere in the life of users, which can com-
promise the motivation to the treatment, 
negatively affecting the quality of life in this 
population.
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intRodUCtion
During a long time, the abusive behavior of substances 
that alter the cerebral functioning causing modifications in 
the mental state, denominated as psychoactive substanc-
es (PAS), was treated with punitive actions for being con-
sidered a moral failure or lack of willpower(1). However, in 
the last two decades, with the progressive development 
of scientific studies, the approach started to be done in a 
preventive and therapeutic way, as it was comprehended 
as a serious health problem, affecting diverse areas of live 
of an individual, with direct or indirect repercussions in 
the quality of life (QL)(2-4).
The QL refers to the individual subjective perception 
of diverse aspects involving physical capacity, functional 
ability, emotional, social and economic aspect, intellectual 
function and general health state perception(5).
Internationally and in Brazil, different instruments 
have been used to assess the QL in diverse populations. 
Within them, the MOS SF-36 (The Medical Outcomes 
Studies 36- Item Short-Form), which assess the health 
related QL and it was translated and validated in Brazil 
in 1997(6), and the WHOQOL (World Health Organization 
Quality of Life) elaborated by the World Health Organiza-
tion to assess the general QL(7).
Thus, facing the proliferation of investigations about 
QL from the 1980s, a study conducted to describe the 
profile of those publications in Brazil found the fulfillment 
and applicability of those instruments in different popula-
tions, with older patients, chronic diseases patients, but 
few studies investigating PAS users were found(8).
The use of PAS negatively interferes in QL of us-
ers affecting directly the psychological, environmental 
and physical self-evaluation aspects(2). In addition, the 
high prevalence of psychiatric disorders in this popula-
tion, confirming the chronic use of PAS as a constitut-
ing a triggering factor or as consequence of psychiatric 
frameworks, especially related to humor disorders and 
depressive mood(9).
Although the scientific literature had discussed harms 
caused by the use of PAS(10-12),studies about the use of 
those and QL have been conducted internationally, ma-
jorly between users of injectable drugs, opioids and/or 
in substitution programs (methadone), noting that the 
use affects QL, with more losses to emotional, mental 
health and social functioning aspects(3-4,13).
In Brazil, studies with this population are still scarce, 
especially those referred to correlate the use of PAS, 
QL and depression in general users, as well as in users 
during treatment in Psychosocial Attention Centers for 
alcohol and other drugs (CAPS-ad). This fact is reiterat-
ed by a study that investigated the scientific production 
about the CAPS during the period of 1998 and 2008, 
identifying a gap in relation to the PAS users and, within 
those, most of them (73.9%) were conducted in the re-
gions south and southeast, leaving the need of studies 
in other regions of Brazil(14).
Considering that chemical dependence brings innu-
merous losses in all life spheres of an individual(10-11), that 
the presence of a comorbidity, as depression, can aggra-
vate and make it difficult the recovery process, affecting 
directly the quality of life and, still, that there is lack of 
data about the theme in the mid-west region, we believe 
that results can contribute to the improvement of politi-
cal strategies directed to attend this population, aiming a 
higher adherence to treatment.
Facing the hypothesis of depressive symptoms hav-
ing an important impact in the QL of SPA users, this study 
aims to assess the correlation between the presence of 
depressive symptoms and the quality of life in users of 
psychoactive substances in Psychosocial Attention Centers 
in Mato Grosso State.
mEtHod
Ethical Aspects
This study was approved by the Ethics in Research 
Committee of the Universidade Federal de São Paulo, un-
der the registration 0556/07 and the participant’s signa-
ture of the Free and Informed Consent Term.
Study design, location and period
A cross-sectional, observational, descriptive and ana-
lytical study, developed in the Psychosocial Attention 
Centers for Alcohol and Other Drugs (CAPS ad) of four 
cities in the state of Mato Grosso: Cuiabá/capital, Várzea 
Grande, Rondonópolis and Barra do Garças, during the 
period of 2009 to 2011.
Population and sample
The population was constituted by users followed in 
the CAPS ad from the four cities considered. The sample 
was obtained by random stratified sampling of CAPS ad, 
proportional to the mean size of the users’ population 
that were in treatment in the CAPS ad on the past 10 
months. Thus, considering a confidence of 95%, a sample 
error of 5%, a proportion of 0.5 and an increase of 20% for 
losses, the sample totalized 109 users in the four CAPS ad.
It is important to note that in this population, the ob-
served users in a set month had also the possibility of 
being observed in the following months. For this reason, 
the average number of individuals per month was used, 
instead of the total number in each city, as it is usual in the 
sampling practice.
Inclusion criteria: users with 18 years old or older using 
illicit PAS.
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Procedures
The data collection was after a pilot test, which 
showed the applicability of the instruments. The inter-
views were done individually, in a reserved environment, 
during a mean time of 40 to 50 minutes, by previously 
trained researchers.
Three instruments were used: 1) Questionnaire 
composed by socio-demographic data and regarding 
the use of PAS during life, nowadays, and in its first use; 
2) QL by the Medical Outcomes Study 36 – Item Short-
Form Health Survey(6), a multi-dimensional instrument 
that assess health related QL, translated, adapted and 
validated in Brazil in 1997, composed by 36 items, divid-
ed in 8 scales or domains: functional capacity; physical 
aspects; pain; general health state; vitality; social as-
pects; emotional aspects and mental health. The scores 
varies from zero (worse health status) and 100 (best 
health status); 3) Beck Depression Inventory(15) (BDI), 
that investigates the presence of depressive symptoms. 
The scale is composed by 21 items, including symp-
toms and attitudes in four levels of intensity (0,1,2,3). 
To define the study cut-point, in accordance with the 
literature, specific scores for non-diagnosed samples 
with affective disorders are considered, in which val-
ues smaller or equal to 15 classified the individuals as 
normal (without the presence of symptoms); 16 to 20 
as dysphoria (sudden, transient changes of mood) and 
superior to 20, suggestive of depression(16).
Statistical analysis of results
The data processing was done with the statistical pro-
grams Statistical Package for Social Sciences (SPSS), ver-
sion 15.0 and MINITAB version 15. Descriptive techniques 
and inferences were used. In the descriptive part, percent-
ages, position measures and variation were used; in the 
inferential part, multiple analysis of variance was used. To 
compare the difference between the means of domains, 
the Tukey’s test for paired comparisons and the Spearman 
correlation was used, with a significance level of α<0,05, 
in both techniques.
RESULtS
In Table 1, it can be observed the average age of us-
ers (29.8 years), with predominance of the male gen-
der (84.4%), single marital status (55.0%), and most of 
them had completed basic education (42.2%), and oc-
cupation (66.1%).
The data presented in Table 2 show the most used 
PAS during life: marijuana (85.3%), base paste (77.0%) 
and cocaine (70.6%). Regarding the actual use, the base 
paste (31.2%), followed by marijuana (30.3%) and cocaine 
(8.3%) were the most used. The first drug used in their 
lives was marijuana (74.3%).
Table 2 – Distribution, in percentage number of the PAS type 
used during life, nowadays and in the first use among PAS users 
from CAPS ad. - Mato Grosso, 2011
Psychoactive Substance (n =109) %*
Use in life
Marijuana 93 85,3
Base paste 84 77,0
Cocaine 77 70,6
Inhalants 32 29,4
Crack 17 15,6
Ecstasy 6 5,5
LSD 3 2,7
Current use
Base paste 34 31,2
Marijuana 33 30,3
Cocaine 9 8,3
First use in life
Marijuana 81 74,3
Cocaine 13 11,9
Base paste 10 9,2
Solvent 5 4,6
* the percentages do not totalize 100% due to the fact that users reported 
the use of more than one pas in all categories.
Table 1 – Distribution, in percentage values, of the socio-de-
mographic characteristics of users of psychoactive substances, 
CAPS ad. – Mato Grosso, 2011
User’s 
characteristics (n =109) %
Age ( x¯ ± DP) 29.8±7.8
Gender Male 92 84.4
Female 17 15.6
Marital Status Single 60 55.0
Married 38 34.9
Divorced 11 10.1
Education Level Incomplete basic education 30 27.5
Complete basic education 46 42.2
Complete high school 30 27.5
Complete higher education 3 2.8
Occupation Possess 72 66.1
Do not possess 37 33.9
The lower scores observed were in the emotional as-
pects domain and the higher in the functional capacity. To 
verify is the mean of the SF36 domains were statistically 
different, a multivariate analysis of variance (ANOVA) was 
used. From this analysis, it was verified the statistical dif-
ference between the scores means of the SF36 (p<0.001). 
To verify which means were different, a multiple compari-
son with the Tukey method, and the different letters in the 
column 2, Table 3, indicate the domains as statistically dif-
ferent in a 5% level.
Regarding the presence of depressive symptoms it was 
observed that 37.6% of users, presented a suggestive cut-
point for depression and 12.8% symptoms of dysphoria.
We can observe in Table 5 a strong correlation between 
the BDI and the SF36 for all domains (p-values<0.05), be-
ing vitality and mental health the ones which highlights.
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In our sample, in relation to marital status, single and 
divorced people formed a 65.14% percentage, that is, a 
big proportion reported as not having a partner or a stable 
relationship. A study demonstrating the risk factors for 
drugs consumption, specially the abusive consumption, 
emphasized that among other variables, marital status 
was an important aspect to be considered(19), a fact that 
was re-affirmed in a tobacco dependency and QL investi-
gation, in which, within the social problems, the ones re-
lated to partners overcame the others(20).
These findings allow hypothesizing that PAS users 
have a higher difficulty in keeping a stable marital rela-
tionship, in consequence of the behavior triggered by the 
use, making affective relationships unstable. This situation 
is grounded as the partners share an environment full of 
conflicts, threats, disqualification and jealousy, reflecting 
in distance and hopelessness(21). It is valid to highlight a 
study with caregivers and chemical dependent individu-
als, conducted in Mato Grosso State in 2010, aiming to 
evaluate the burden of care that found most of caregivers 
as wives, and those presented depression symptoms and 
lack of sexual interest, which was the most contributing 
factor to this situation(22), confirming the difficulty to live 
with this adverse situation.
In accordance with the level of education, there was a 
predominance of users who only completed basic educa-
tion. The low level of education within PAS users can be 
attributed, within other factors, to the lack of motivation 
and the discontinuity of investment in education, inter-
rupting early education activities. Studies show that low 
school performance is associated with heavy use of alco-
hol and other drugs, with possibility to cause neuropsy-
chological alterations with learning loss, causing low per-
formance, leading to low self-esteem and interruption of 
academic activities(19).
The low level of education, allied with the fact of a 
third of the study population had referred to have none 
occupation at the moment of the research, calls attention 
to the lack of professional qualification and low insertion 
in the job market, interfering in the perspective of social 
reinsertion.
In relation to PAS, the inhalants (denominated solvents, 
as loló, lança-perfume and others) are the most used sub-
stances in Brazil. Thus, in the south of the country the mari-
juana assumes this position(19), an evident fact in this study 
in which the higher proportion of users referred to mari-
juana as the most used PAS. A study conducted in Rio de 
Janeiro-RJ, corroborates with this finding, pointing to mari-
juana as the most used illicit drug, with a 77.8% prevalence, 
followed by crack/cocaine, with 58.6%(23). The easy access 
to drugs, as well as the low cost and, still, the fact of mari-
juana being considered a less aggressive drug and with less 
social stigma, can contribute to the increase of its use.
A study discussing the extent of damage from the use 
of marijuana found that within those who experimented 
diSCUSSion
The findings of the present study, in relation to the 
average age of users, are similar to the means obtained 
in other studies, as well as the high prevalence of PAS 
among the male users(11,16). The pattern analysis of alco-
hol and drugs consumption in a representative sample of 
the Brazilian urban population demonstrated a significant 
difference in some moment of life in males in relation to 
females(11). In this context, studies about the prevalence 
and incidence of PAS use, although the divergences in the 
consumption patterns within countries, it is common to 
report males as major consumers(17).
Although there is a social prejudice in relation to any 
substance dependency, women are still more stigmatized 
in comparison to men. More aggressive stereotypes are 
attributed to them, a tendency to promiscuity and failures 
in following their family role. Besides all changes in social 
roles of men and women, this stereotype is still present, 
making the access of those women to treatment difficult. 
This way, women are generally under-represented in ther-
apeutic centers(18).
Table 5 – Spearman correlation coefficients between the SF-36 
domains and BDI. CAPS ad. – Mato Grosso. 2011
Dimension Beck Depression Inventory* p**
Functional capacity -0.463 <0.001
Physical aspect -0.465 <0.001
Pain -0.446 <0.001
General health status -0.557 <0.001
Vitality -0.596 <0.001
Social aspects -0.541 <0.001
Emotional aspects -0.301 0.001
Mental health -0.714 <0.001
*spearman correlation coefficient (ρ).
**p = p-value associated to the spearman correlation test (ρ).
Table 4 –Beck Depression Inventory (BDI) descriptive statistics 
of the PAS users., CAPS ad. – Mato Grosso, 2011
Beck Depression Inventory (n=109) %
Depression 41 37.6
Dysphoria 14 12.8
Normal 54 49.6
Total 109 100.00
Table 3 – Descriptive statistics of the SF-36 domains of PAS us-
ers, CAPS ad. – Mato Grosso, 2011
SF36 Domains x¯ ± EPM
Functional capacity 86.47 ± 1.64 A**
Physical aspect 66.06 ± 3.33 B**
Pain 62.23 ± 2.66 B**
General health status 65.59 ± 2.06 B**
Vitality 66.19 ± 2.17 B**
Social aspects 60.72 ± 2.85 B**
Emotional aspects 44.32 ± 3.99 C**
Mental health 60.22 ± 2.25 B**
**the capital letters (a, b and C) indicate the domains which presented in average 
differences statistically significant, through the tukey test at a 0,05 level.
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the substance, an average of 10% became daily users and 
20 to 30% will consume it weekly(12). Although the cere-
bral alterations from the use of marijuana are more subtle 
when compared to other PAS, it does not mean the non-
existence and relevance of it. Therefore, as the consump-
tion can cause damages, within them the mental disor-
ders(12), the subject is particularly important to the mental 
health team in the planning and implementation of care.
In the present study, the base paste was the second 
most used PAS during life, appearing in first place for actu-
al use within the users in treatment. The base paste of co-
caine (PBC) is common in the Brazilian regions north and 
mid-west, it is handcraft prepared in improvised laborato-
ries especially to keep its low cost. Many toxic substances 
are added to it, provoking an adulteration in it with high 
concentration of those toxic products(24), exposing the us-
ers to many diverse organic and psychiatric damages.
It is important to note that users reported the conti-
nuity of PAS use during the data collection. This situation 
can be related to the non-priority of total abstinence as 
basic premise to the treatment in the service, an actual 
policy assumed by the CAPS ad, of Damage Reduction. 
In this perspective, the results are sought in a long term 
period, the abstinence is a consequence and the atten-
tion is focused on the damages caused by drugs and not 
in the drug itself. In this matter, it is believed to have 
more incentive to treatment, besides the possibility of 
an active posture from the user regarding the continuity 
of the use or not, that is, a self-responsibility during the 
therapeutic process.
The results related to the first drug used in life allow 
inferring that in similarity to other investigations, in this 
study there was a predominance of marijuana. A national 
research in 2008 pointed that 80.1% of interviewed peo-
ple used marijuana in their first time consuming PAS, and 
from those 79.6% had it from friends, family members or 
people they knew(11). The initial use of any PAS aims to as-
pects as social acceptance, challenging norms, and desire 
to feel the substance effect within others. Independently 
of the motive for its use, it normally starts during adoles-
cence, intensifying the demand for preventive programs 
for this age group(25) aimed to the reduction of damages 
from the early use, propitiating better conditions of QL.
The use of PAS and QL have been discussed in its ma-
jority in American studies, showing that within PAS users, 
lower scores of QL when compared to the general popula-
tion and with other patients with chronic diseases(4,13).
In Brazil, the results are not different. A study from 
Pelotas-RS verified a significant association between low-
er scores of QL and the use of alcohol and/or other drugs. 
In our study population, the QL scores were considerably 
lower in comparison to QL scores from the general popu-
lation from this city(26), reinforcing the negative influence 
of the PAS use in the subjective perception of QL.
Considering the QL as a subjective outcome, it should 
be assessed by different domains. In this study, the most 
compromised domains were the emotional, mental and 
social aspects. Similar results were obtained in an investi-
gation in Canada, comparing the QL of patients in severe 
medical conditions and opiates users, especially for the 
social, emotional aspects, energy and vitality and, still, 
limitations caused by mental disorders(3).
In the last decade, the occurrence of mental disorders 
and the PAS use have been largely recognized in the psy-
chiatric clinic, with emphasis for depressive symptoms(27). 
This way, the evident depressive symptoms in more than 
one third of the study sample are in accordance with 
the findings obtained for this population, in which the 
percentages were 35.0%(19) and with a variation of 30 to 
50.0%, respectively(27).
The depressive symptoms have been the most stud-
ied within the psychiatric disorders in relation to quality 
of life(28), and it was observed in the present study a strong 
correlation between the depressive symptoms and all QL 
domains. This correlation results in the QL decline of users 
as depression increases the pain sensation and the func-
tional capacity, decreases the quality of the social relation-
ships and makes the adherence to the treatment harder(29).
We observed the domains strongly correlated with de-
pression symptoms were mental health, involving psychic 
alterations, as well as the feeling of sadness, anxiety and 
others, and the vitality domain, referred to energy for rou-
tine activities, disposition and the relationship with the 
will to transform decisions in actions. This identification 
allow the planning of strategies more directed with focus 
in individual needs, aimed to facilitate the adherence to 
treatment and recovery, propitiating the restart of activi-
ties of body care, leisure, social activities and others.
It is important to emphasize that although the litera-
ture shows evidence of the correlation between depres-
sion and QL, nowadays, it has been discussed if the QL 
concepts and depression are overlapped or distinct(28), 
due to both being based in a theoretical model of well-
being, that depression can cause negative influence in 
the perception of QL and, still, that QL evaluates psycho-
pathological aspects, as depressive symptoms(28,30).
On the other hand, there is evidence that QL of de-
pressed individual are not only associated to the presence 
of depressive symptoms, but there is also different psy-
chosocial variables, suggesting that depression and QL are 
correlated concepts, but distinct(30).
Even when facing questions referred to its theme that 
seem to be still inconclusive, there is a consensus in the lit-
erature that the association between depression and qual-
ity of life represent an impact in the individual’s live, be-
ing relevant the comprehension of the applicability of the 
quality of life concept in health care, as well as the method-
ological limitations involved in the study of this measure(28).
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The obtained data in the study reaffirm the hypothesis 
of the presence of depressive symptoms having an impor-
tant impact in the quality of life. Thus, the assessment of 
quality of life seem to be a relevant outcome, because its 
multidimensionality is potentially capable to detect the 
magnitude and the broadness of compromise that de-
pression imposes(28).
It is important to note that our study design does not 
allow the establishment of causal relationships. Therefore, 
longitudinal studies can be done aiming to establish with 
more clarity the relationship between depression and QL.
The study findings reaffirm the need for efforts within 
the multi professional team, for the whole evaluation of 
the user, as well as for the diagnostic elucidation, aiming 
adequate therapeutic institutions to attend the symptoms 
and improve the QL.
It is important to highlight that in Brazil, and more 
specifically in Mato Grosso State, studies of attention 
services to PAS users using evaluation translated and vali-
dated scales are scarce. Therefore, few limitations should 
be considered, as the bibliographic search which showed 
a reduced number of studies conducted with this instru-
ment, for this population, and within the few found stud-
ies, a major part of them were international, making the 
comparison with our population difficult as they are from 
another reality. For this reason, we searched for studies 
with PAS users with other methodologies, aiming to ob-
tain a parameter to analyze the data.
ConCLUSion
We found scores indicating the QL concerning of PAS 
users, as well as a strong correlation with depression 
symptoms. These data contribute with the direction of 
nursing and multi professional interventions, showing 
the need to recognize earlier depression symptoms that 
compromise therapeutic effectiveness, which makes the 
adherence to treatment difficult and affect negatively the 
QL of users. The recognition of those symptoms, as well as 
its correlation with QL, makes possible the implementa-
tion of actions directed to individual and collective needs, 
consequently, an improvement in QL.
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